NeuroSense Therapeutics
NRSN
NRSN
8 hedge funds and large institutions have $112K invested in NeuroSense Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$10K | |
| 2 | +$9.39K | |
| 3 | +$2.36K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$42 |